Roche Stock: Comment On Q1 Results (OTCMKTS:RHHBY)
Roche's Q1 report beats expectations and RHHBY confirms the 2022 targets. Revenues up by more than 10% thanks again to the diagnostics division. Read more here.
Source: seekingalpha.com
Stay updated with breaking news from Roche Achilles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche's Q1 report beats expectations and RHHBY confirms the 2022 targets. Revenues up by more than 10% thanks again to the diagnostics division. Read more here.